More PRNewswire
View Older Stories View Newer Stories-
LG ELEVATES WEBOS GAMING EXPERIENCE WITH LG MAGIC REMOTE-OPTIMZED GAMES
-
Study Results from COTA, PreciseDx, and Baptist Health South Florida Confirm Novel AI Test, PreciseBreast is Equivalent to Oncotype DX at Predicting Breast Cancer Recurrence
-
Symphony Talent Earns Gold & Silver at Brandon Hall Group's 2024 Excellence in Technology Awards
-
LANDSEA HOMES CLOSES ON 32 HOMESITES IN THE CHERRY MEADOWS MASTER-PLANNED COMMUNITY IN BRIGHTON, COLORADO
-
Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company
-
Ontinue Named a Strong Performer in Gartner Peer Insights™ Voice of the Customer for Managed Detection and Response
-
Generac Promotes Amanda Teder to Chief Marketing Officer
-
Agri Spray Drones Partners with EAVision to Advance US Agricultural Spray Drone Technology
-
AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease
-
Sercomm and Harmonic Announce Strategic Collaboration on DOCSIS 4.0 Unified Technology
-
ASHFORD HOSPITALITY TRUST ANNOUNCES CONVERSION OF LA CONCHA KEY WEST TO MARRIOTT'S AUTOGRAPH COLLECTION
-
Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications
-
Koppers Announces Retirements of Leslie Hyde and Joseph Dowd
-
GDS International's Series B Equity Raise Upsized To US$1.2 Billion Amid Strong Investor Support
-
Oak Ranch Manufactured Homes Community in Expands to Offer Over 180 Energy-Efficient Homes in Austin, Texas
-
Recognize Announces Strategic Investment in SDG Corporation
-
Miami-Dade County Commission Vice Chairman Kionne L. McGhee Honors Dr. Desmond Meade with Street Naming Ceremony
-
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
-
Hair Growth Drug Safe at Low Doses for Breast Cancer Patients
-
The U.S. Department of Homeland Security, Israel's National Cyber Directorate, and the BIRD Foundation, Announce a Cybersecurity Call for Proposals
-
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
-
Canopy Growth and Acreage Confirm Canopy USA's Completed Acquisition of Acreage
-
Omnicom to Acquire Interpublic Group to Create Premier Marketing and Sales Company
-
Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
-
Ballard to Supply 8 MW of Fuel Cell Engines to Stadler for Californian Passenger Rail
-
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymp
-
Defense Metals Announces Release Date of its Wicheeda Rare Earth Element Project PFS
-
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
-
Mason Capital Management-Led Consortium Completes Acquisition of CB&I
-
PAINTEQ SECURES GROUNDBREAKING PATENT FOR LINQ® TECHNOLOGY, ADVANCING PRECISION AND EFFICIENCY IN SI JOINT FUSION
-
American bespoke Coaching and Psychiatry practice The Open Sea Institute showcased in new book to celebrate 120 years of Rolls-Royce
-
Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
-
Chandler couple opens Caring Senior Service to bring trusted support and companionship to local families
-
Women in HVACR records largest endowment fund donation to date
-
VERSABANK TRANSITIONS CORE TEAM RESPONSIBLE FOR CANADIAN RECEIVABLE PURCHASE PROGRAM SUCCESS TO LEAD US OPPORTUNITY
-
Perpetua Resources and Sunshine Silver Announce Agreement to Advance Domestic Antimony Supply Chain
-
METALLA ANNOUNCES APPOINTMENT OF CHRIS BEER TO BOARD OF DIRECTORS
-
Apax Funds to Sell Minority Stake in AssuredPartners to Arthur J. Gallagher & Co.
-
LOMOND THERAPEUTICS REPORTS RESULTS FROM ONGOING CLINICAL STUDIES OF LONITOCLAX, A SELECTIVE BCL-2 INHIBITOR WITH BEST-IN-CLASS SELECTIVITY VERSUS BCL-XL AND NO CYP 3A4 LIABILITY
-
GTCR Announces Sale of AssuredPartners to Arthur J. Gallagher & Co. for $13.45 Billion
-
Riot Platforms Announces Proposed Private Offering of $500 Million of Convertible Senior Notes
-
Aircastle Delivers the First of Six 737MAX9 Aircraft to United Airlines
-
Datadog Announces Proposed Private Offering of $775 Million of Convertible Senior Notes
-
VERSABANK DECLARES DIVIDENDS
-
CVS Health Corporation Announces Expiration and Results of Any and All Tender Offer
-
Movement Network Foundation Announces Launch of Movement Mainnet Beta and $MOVE Token Generation Event
-
VERSABANK FOURTH QUARTER AND FISCAL 2024 RESULTS CONTINUE TO DEMONSTRATE STRENGTH OF BUSINESS MODEL AS BANK LAUNCHES PROVEN RPP SOLUTION IN US MARKET
-
Wayfair Professional Unveils 2025 Design Trends
-
Startup World Cup 2025 CES Las Vegas - Win $1M Investment Prize!
-
Lodging Dynamics Hospitality Group Welcomes Hospitality Veteran Lisa Carlson as Chief Operating Office
